Canada's Cold Chain Crisis: A New Alliance Aims to Fortify a Critical Link

BROOMFIELD, CO & TORONTO, ON – September 15, 2026 – The future of medicine is arriving in temperature-sensitive vials and syringes. From advanced biologics that target cancer with cellular precision to the mRNA vaccines that redefined pandemic response, a new generation of therapeutics demands an unbroken, precisely controlled cold chain. This logistical backbone of modern healthcare is now under unprecedented strain, and in Canada, a new strategic alliance is forming to reinforce it.

Swisslog Healthcare, a global leader in pharmacy and transport automation, has announced a landmark partnership with PharmaSystems, a deeply entrenched Canadian distributor of pharmacy supplies. The collaboration will bring Swisslog Healthcare's Tenutō Cold Chain portfolio of medical-grade refrigerators and freezers to healthcare facilities across Canada, addressing a critical and rapidly growing infrastructure need.

The Unseen Pressure on a Nation's Health

The demand for specialized cold storage is not a niche requirement; it is fast becoming the standard. According to data from the American Society of Health-System Pharmacists, a staggering 43% of all new drugs approved between 2018 and 2023 require cold chain storage. This trend is driven by the explosion in biologics, cell and gene therapies, and other complex specialty medications that are highly sensitive to temperature fluctuations. For these high-value treatments, a minor deviation from the required 2-8°C range can render them ineffective or even unsafe, resulting in significant financial loss and, more critically, a potential disruption in patient care.

This challenge is amplified by Canada's stringent regulatory environment. Health Canada enforces rigorous guidelines for the storage and handling of temperature-sensitive pharmaceuticals to protect public health. This puts immense pressure on hospitals, pharmacies, and laboratories to upgrade from legacy or consumer-grade refrigeration to purpose-built systems that guarantee temperature stability, provide meticulous data logging, and offer robust alarm capabilities. The COVID-19 pandemic served as a global stress test for cold chain logistics, exposing vulnerabilities and accelerating the urgency for investment in reliable infrastructure.

"Building a trusted partner network is central to our strategy for making the Tenutō Cold Chain portfolio accessible to healthcare facilities around the world," said Cory Kwarta, CEO of Swisslog Healthcare, in a statement. "Together with PharmaSystems, we will ensure that Canadian pharmacies and laboratories have access to purpose-built cold storage solutions as the demand for specialty medications continues to accelerate."

A Strategic Synergy of Technology and Trust

This partnership represents a powerful synergy between technological innovation and established market expertise. Swisslog Healthcare, a member of the KUKA Group, brings a legacy of intelligent automation and precision engineering. Its Tenutō portfolio is designed to meet the exacting demands of modern medication management. However, introducing specialized medical hardware into a complex and highly regulated market like Canada requires more than just a superior product; it requires trust, established relationships, and a deep understanding of local logistics and compliance.

This is where PharmaSystems becomes the crucial link. Founded in 1977, the Canadian-owned company has spent nearly five decades building a reputation as a cornerstone supplier for the nation's healthcare facilities. Its extensive distribution network, bilingual customer support, and, crucially, its adherence to regulatory standards—including a Medical Device Establishment Licence and ISO 13485 certification for medical device quality management—make it an ideal partner. For Swisslog Healthcare, this alliance provides immediate, credible access to a market where it already has a foothold with its other automation solutions.

"Swisslog Healthcare's Tenutō Cold Chain portfolio gives our customers access to purpose-built refrigeration equipment that meets the demands of today's pharmacy and laboratory environments," noted Hilary Lieberman, Vice President of Business Development at PharmaSystems. "We have spent nearly five decades building relationships with Canadian healthcare facilities, and this partnership allows us to bring them a trusted, high-performance solution that addresses one of the fastest-growing needs in the industry."

Inside Tenutō: The Next Generation of Medical Refrigeration

The term "purpose-built" is central to understanding the value proposition of the Tenutō line. Unlike a standard commercial or domestic refrigerator, these medical-grade units are engineered for one purpose: protecting the integrity of high-stakes medical products. This involves features far beyond simple cooling.

Tenutō systems are designed for superior temperature uniformity, ensuring consistent conditions from top to bottom, and rapid temperature recovery after door openings, a frequent occurrence in busy pharmacies and labs. They incorporate sophisticated digital controls and monitoring systems that provide real-time data logging, a critical requirement for regulatory audits. Advanced alarm systems immediately notify staff of any temperature deviations, power failures, or door-ajar events, enabling swift intervention to prevent product loss.

In a landscape with established competitors like Thermo Fisher Scientific and Helmer Scientific, the combination of Tenutō's technological capabilities with the distribution prowess of PharmaSystems creates a compelling new option. The partnership promises not only to deliver the hardware but also to provide the comprehensive local support, service, and expertise that healthcare facilities depend on.

"As more specialty medications enter the market, the need for reliable, high-performance cold storage in hospitals and pharmacies has never been more urgent," explained Michael Palone, Pharmacy Affairs Executive at Swisslog Healthcare. "Partnering with established distributors like PharmaSystems allows us to reach more facilities across Canada that are managing increasingly complex and high-value medication inventories, while providing the level of expertise and trust those customers expect."

Reshaping Medication Management from Coast to Coast

The ripple effects of this partnership are poised to be significant for Canadian healthcare providers. For hospital administrators and pharmacy directors, it offers a streamlined path to upgrading critical infrastructure, enhancing compliance, and mitigating the financial risks associated with medication spoilage. By ensuring the stability of increasingly expensive inventories, these advanced refrigeration systems provide a clear return on investment.

For pharmacists and lab technicians on the front lines, it means greater confidence in the efficacy of the products they handle and dispense. The reduction in manual temperature logging and the reliability of automated monitoring frees up valuable time for patient-facing activities. Ultimately, the greatest impact is on patient safety. Ensuring a medication has been stored correctly throughout its journey is a non-negotiable element of quality care.

By uniting advanced automation technology with a deeply rooted Canadian distribution network, Swisslog Healthcare and PharmaSystems are not merely selling equipment; they are delivering a comprehensive solution to one of the most pressing challenges in modern healthcare. This alliance sets a new benchmark for how technology innovators can effectively deploy critical solutions, strengthening the very foundation of medication management across the country.